Viewing nowNeuropain Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Unimed Pharmaceutical Co., Ltd.

MFDS item code 201109296 · Approved 2011.10.31 · Insurance code 649506030
Relief of peripheral and central neuropathic pain, adjunct for partial seizures in epilepsy, treatment of fibromyalgia
This medicine is used for treating peripheral and central neuropathic pain in adults. It is also utilized as an adjunct for partial seizures in patients with epilepsy and is effective even when there are secondary general symptoms. Additionally, it helps alleviate symptoms of fibromyalgia. Overall, this medication is effective for neuropathic pain, epilepsy, and fibromyalgia treatment.
This medication is administered orally divided into two doses per day regardless of meals. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg per day, increasing to 300 mg per day within 3 to 7 days, may be increased to a maximum of 600 mg per day if necessary. - Central neuropathic pain: Starting dose of 150 mg per day, increasing to 300 mg per day after one week, followed by an additional increase to 600 mg per day after another week.
For children under 12 years and adolescents aged 12 to 17, safety and efficacy data are insufficient, so administration is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or symptoms of depression appear during treatment, it is essential to consult a doctor immediately. Patients with allergies to any components of this medication or specific genetic lactose metabolism disorders should not take it. Diabetic patients should be cautious as weight gain may require adjustments to blood glucose control medications. If symptoms of severe allergic reactions such as angioedema occur, discontinue the medication immediately and consult medical personnel. Elderly individuals should be careful during the initial doses due to the risk of dizziness or drowsiness leading to falls. Visual disturbances such as blurred vision may occur, and if symptoms persist, consultation with a physician is recommended. Withdrawal symptoms such as insomnia, headache, and anxiety may emerge after discontinuation, so abrupt cessation should be avoided. Patients with a history of drug abuse may have a higher risk of misuse of this medication, so caution is advised during use. Patients with impaired renal function may require dose adjustments. Patients with severely compromised cardiac function should use this medication cautiously. When taking with other drugs that have central nervous system depressant effects, there is an increased risk of drowsiness or respiratory depression, so caution is required. During early pregnancy, it may affect the fetus, so it should generally not be used, except in special circumstances, and women of childbearing age should use effective contraception. Lactating women should consider discontinuing breastfeeding or the medication, as this medication can be transmitted through breast milk. This medication may cause dizziness and drowsiness, so it is advisable to avoid driving or operating hazardous machinery after taking it. Serious skin reactions may occur rarely, so if any unusual symptoms such as rash or swelling appear, inform medical personnel immediately. In the case of overdose, symptoms such as confusion, drowsiness, and seizures may occur, so the prescribed dosage must be followed. Blood dialysis may be necessary if required. Special precautions are necessary for children and the elderly, and children should be kept out of reach of this medication.
Hives, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, peeling skin, pain in oral/ocular mucous membranes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and very severe headache, thunderclap headache, seizures, disorientation, visual disturbances, coma
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it must be stored in a tightly closed container. It is advisable to maintain the storage temperature between 15 to 30 degrees Celsius. Proper storage helps preserve the medication's effectiveness over time.
A white or pale yellow powder contained in white hard capsules with white upper and lower parts.
30 capsules/bottle, 200 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.